Clinical Trial Update: Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 1]

View source ↗

Summary

Phase 1 study of KHK2823 in Acute myeloid leukemia and myelodysplastic syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• KHK2823

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED